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Background
Lopinavir boosted by ritonavir is one of the most pre-
scribed HAART during pregnancy. This study used the
human cotyledon-perfused model to investigate different
elements (albumin concentrations, High-molecular
weight antiviral (enfuvirtide, 4491 g/mol) and P-glyco-
protein inhibitor drugs (ciclosporin, 1202 g/mol)) that
modulate its placental transfer.
Methods
Thirteen human cotyledons were perfused with different
concentrations of albumin (10, 20, 30, 40 g/L). Ciclo-
sporin A (n = 11) and enfuvirtide (n = 2) were respec-
tively coperfused at middle time of the perfusion.
Clearance index (CI) of lopinavir and ritonavir were
compared at different albumin concentrations and
between control and ciclosporin or enfuvirtide phases.
Results
The CI of lopinavir was significantly lower at physiolo-
gic (30 and 40 g/L) albumin concentrations in control
phases (p < 0.0001). When adding ciclosporin A at phy-
siological albumin concentrations, the CI of lopinavir
increased significantly 10.3 fold (p = 0.046) and became
positive for ritonavir. The mean CI of lopinavir was
0.184 ± 0.169 in the control phase and 0.253 ± 0.239
following the addition of enfuvirtide, wich is 1.4 times
higher but not statistical significant (p= 0.39). There was
no placental transfer of ritonavir at baseline and no var-
iation after adding enfuvirtide. Even at supraphysiologic
concentration, enfuvirtide did not cross the placenta.
Discussion
This study suggests that the most influent event for pla-
cental transfer of highly bound drug like lopinavir dur-
ing pregnancy is the physiologic variation of serum
albumin. P-glycoprotein expression on human placenta
has also a role but seems to be slighty. Also the compe-
tition with another antiviral highly bound drugs like
enfuvirtide (92%) has a little but not significant effect on
placental transfer of lopinavir.
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